Michael Kyriakides
Director/Board Member at Purespring Therapeutics Ltd.
Profile
Michael Kyriakides is an Investment Partner of Syncona Investment Management Ltd.
He works closely with Syncona portfolio companies Freeline Therapeutics and Clade Therapeutics.
Previously, Michael was a member of the Life Sciences team at L.E.K.
Consulting, where he worked in projects for pharmaceutical, biotech and private equity clients.
Prior to joining L.E.K.
Consulting, he was a clinical project and NMR manager in the Faculty of Medicine at Imperial College London.
Michael obtained his doctorate degree in toxicology and metabolic profiling at Imperial College London.
Syncona portfolio companies
Freeline Therapeutics
Clade Therapeutics (Board observer)
Purespring Therapeutics (Board member)
Michael Kyriakides active positions
Companies | Position | Start |
---|---|---|
Syncona Partners LLP
Syncona Partners LLP Investment ManagersFinance Syncona Partners LLP (Syncona Partners) is a venture capital subsidiary of Syncona Investment Management Ltd. founded in 2012 by Martin Murphy. The firm is headquartered in London, United Kingdom. | Private Equity Investor | 2018-07-31 |
Purespring Therapeutics Ltd.
Purespring Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Purespring Therapeutics Ltd. provides biotechnological research and experimental development services. The company was founded on April 1, 2020 and is headquartered in London, the United Kingdom. | Director/Board Member | 2022-03-31 |
Training of Michael Kyriakides
Imperial College London | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Syncona Partners LLP
Syncona Partners LLP Investment ManagersFinance Syncona Partners LLP (Syncona Partners) is a venture capital subsidiary of Syncona Investment Management Ltd. founded in 2012 by Martin Murphy. The firm is headquartered in London, United Kingdom. | Finance |
Purespring Therapeutics Ltd.
Purespring Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Purespring Therapeutics Ltd. provides biotechnological research and experimental development services. The company was founded on April 1, 2020 and is headquartered in London, the United Kingdom. | Commercial Services |
- Stock Market
- Insiders
- Michael Kyriakides